Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7f7572ee-64ec-45b1-9176-1605f699aa70 Date 1/13/2014 Company Name RideApart Mailing Address 3522 Hayden Ave Culver City, CA 90232 Company Description RideApart provides consumers with substantial, 21st century shopping and research tools to guide motorcycle purchases. Shopping for parts, accessories and financial products are a substantial component of that research in RideApart’s Buyer’s Guide. Website http://www.rideapart.com … Continue reading “RideApart Obtains $47,000 New Round”
Author: VentureDeal
Ivantis Receives $14,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9c18706-d2bb-4806-a7bc-3455f1be4583 Date 1/13/2014 Company Name Ivantis Mailing Address 38 Discovery Irvine, CA 92618 Company Description The company provides medical devices for the treatment of glaucoma. Website http://www.ivantisinc.com Transaction Type Venture Equity Transaction Amount $14,000,000 Transaction Round Series B Proceeds Purposes The funds will support the Company’s three large ongoing clinical trials, including … Continue reading “Ivantis Receives $14,000,000 Series B Funding”
KineMed Receives $6,442,287 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=23fea6a9-5c6b-4e6a-8953-1779c0cc366b Date 1/13/2014 Company Name KineMed Mailing Address 5980 Horton Street Emeryville, CA 94608 Company Description KineMed, Inc. is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag and KineMarker) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies. … Continue reading “KineMed Receives $6,442,287 New Funding Round”
Axcient Lands $12,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=71c5dc76-0099-4272-986c-38118838057b Date 1/13/2014 Company Name Axcient Mailing Address 1161 San Antonio Rd. Mountain View, CA 94043 Company Description Axcient offers the first plug-and-play data protection service to make business continuity and online backup simple for small and medium sized businesses (SMB). Axcient incorporates an onsite data backup and replication management appliance with … Continue reading “Axcient Lands $12,000,000 New Funding Round”
Axcient Receives $12,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=71c5dc76-0099-4272-986c-38118838057b Date 1/13/2014 Company Name Axcient Mailing Address 1161 San Antonio Rd. Mountain View, CA 94043 Company Description Axcient offers the first plug-and-play data protection service to make business continuity and online backup simple for small and medium sized businesses (SMB). Axcient incorporates an onsite data backup and replication management appliance with … Continue reading “Axcient Receives $12,000,000 New Financing Round”
Nina Biotherapeutics Obtains $877,688 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=92b78b85-7594-4313-88b3-8b8e004d7655 Date 1/13/2014 Company Name Nina Biotherapeutics Mailing Address 3260 Bayshore Blvd. Brisbane, CA 94005 Company Description The company is developing therapies to combat cachexia in cancer patients. Website Undisclosed Transaction Type Venture Equity Transaction Amount $877,688 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology … Continue reading “Nina Biotherapeutics Obtains $877,688 New Funding”
Pinta Biotherapeutics Garners $6,311,156 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1ca92e14-7ef4-4612-a9ad-d20a80486f35 Date 1/13/2014 Company Name Pinta Biotherapeutics Mailing Address 3260 Bayshore Blvd. Brisbane, CA 94005 Company Description The company is developing therapies to reverse protein energy wasting in renal disease. Website Undisclosed Transaction Type Venture Equity Transaction Amount $6,311,156 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. … Continue reading “Pinta Biotherapeutics Garners $6,311,156 New Financing”
LiveIntent Receives $9,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa1f8f98-3c8a-4c15-8519-8df2dafe7fb9 Date 1/13/2014 Company Name LiveIntent Mailing Address 100 Church Street 7th Floor New York, NY 10007 Company Description LiveIntent is an Email Advertising and Trading Desk company with the first technology for email and display designed to support brand and direct response advertisers and agencies. Website http://www.liveintent.com Transaction Type Venture Equity … Continue reading “LiveIntent Receives $9,000,000 New Round”
Vengo Lands New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c39a9a4-4334-4394-bcc5-c3a830d9f2ee Date 1/13/2014 Company Name Vengo Mailing Address Undisclosed New York, NY 10001 Company Description Vengo…convenience on the go. Life is unpredictable. Planning ahead is hard. Vengo is for the things you forgot…or maybe you didn’t know you needed. So go Vengo and get back to it! Website http://www.vengolabs.com Transaction Type Venture … Continue reading “Vengo Lands New Round”
Facebook Acquires Branch for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b82a3d40-7674-41e1-8ffa-1a53d5c547d4 Date 1/13/2014 Company Name Branch Mailing Address 220 East 23rd St. New York, NY 10010 Company Description Branch aims to offer meaningful conversations through online discussions. Website http://www.branch.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms No financial terms were disclosed, but The Verge reports around a … Continue reading “Facebook Acquires Branch for Undisclosed Sum”
Groupon Acquires ideeli for $43,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8b45620f-b8b1-4a60-8f58-9069a2c51556 Date 1/13/2014 Company Name ideeli Mailing Address 374 West 11th Street New York, NY 10014 Company Description Ideeli is online shopping community that connects luxury brands with the consumers who covet them through computers, emails or cell phones. Website http://www.ideeli.com Transaction Type M&A Transaction Amount $43,000,000 Transaction Round Proceeds Purposes M&A … Continue reading “Groupon Acquires ideeli for $43,000,000”
Rebellion Photonics Secures $10,400,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dbb8cfbf-1070-4fd4-bb9b-8d78d7ddb84d Date 1/13/2014 Company Name Rebellion Photonics Mailing Address 7547 South Fwy Houston, TX 77021 Company Description Rebellion Photonics is commercializing the unique ‘snap-shot’ hyperspectral imaging technology. Our main product is the Gas Cloud Imaging camera for oil and gas safety. The company was founded in 2009 and is headquartered in Houston, … Continue reading “Rebellion Photonics Secures $10,400,000 Series A Funding”
Iconixx Software Garners $4,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8751478d-3999-4b4d-8e13-a810afb19e43 Date 1/13/2014 Company Name Iconixx Software Mailing Address 3420 Executive Center Dr. Austin, TX 78731 Company Description Iconixx Total Compensation Software (TCS) leverages SaaS technologies to deliver consistent Sales Performance Management and Incentive Compensation Management to customers – Small Business, Mid-Market, and Enterprise on one organic solution with a native workflow … Continue reading “Iconixx Software Garners $4,500,000 New Round”
Juno Therapeutics Receives $25,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c2ed67b3-5a17-46d1-9cd2-15161cf481ed Date 1/13/2014 Company Name Juno Therapeutics Mailing Address 307 Westlake Avenue North Seattle, WA 98109 Company Description Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership … Continue reading “Juno Therapeutics Receives $25,000,000 Series A Round”
Kontagent Lands $4,793,334 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a8a89280-f3aa-4ab5-96fc-ddfd1ef81e3b Date 1/13/2014 Company Name Kontagent Mailing Address 201 Mission Street 25th Floor San Francisco, CA 94105 Company Description Kontagent is the leading viral analytics platform for social network application developers. The Kontagent platform has been built from the ground up to provide deep social data visualization and analysis that delivers actionable … Continue reading “Kontagent Lands $4,793,334 New Funding Round”
Google Acquires Nest for $3,200,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=202fa098-e49f-4e50-b917-69c0ddc4d5d8 Date 1/13/2014 Company Name Nest Mailing Address 900 Hansen Way Palo Alto, CA 94304 Company Description Nest is focused on addressing home-energy consumption with an elegantly designed solution – one that people actually enjoy using. Website http://www.nest.com Transaction Type M&A Transaction Amount $3,200,000,000 Transaction Round Proceeds Purposes M&A Terms The acquisition … Continue reading “Google Acquires Nest for $3,200,000,000”
Aeglea BioTherapeutics Receives $12,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f6aa5d0-fc91-462b-939a-29d701bf8586 Date 1/13/2014 Company Name Aeglea BioTherapeutics Mailing Address 815-A Brazos St. Austin, TX 78701 Company Description Aeglea BioTherapeutics is a Texas based start up developing two drugs invented at UT Austin, novel engineered human enzymes that degrade the amino acids L-methionine (L-Met), or L- arginine (LArg) in the circulation. These drugs … Continue reading “Aeglea BioTherapeutics Receives $12,000,000 New Financing”
Volusion Lands $35,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=997db2f5-4c96-4d75-a298-cf8229e7614c Date 1/13/2014 Company Name Volusion Mailing Address 8911 Capital of Texas Hwy. Austin, TX 78759 Company Description Success is about more than sales and revenues. The true measure of company’s success isn’t how much they make or how many awards they win. It’s about the impact they make on the people, … Continue reading “Volusion Lands $35,000,000 New Funding”
NowThis Media Garners New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c18e8129-1582-4850-a351-ece4e50697f3 Date 1/12/2014 Company Name NowThis Media Mailing Address 560 Broadway New York, NY 10012 Company Description NowThis Media operates NowThis News – a TV-style news website, to appeal to people who normally watch. Website http://www.nowthisnews.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes The two companies will … Continue reading “NowThis Media Garners New Funding”
HireVue Acquires Reschedge for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=862e2e0c-5292-4a36-a780-0324b4a593cd Date 1/12/2014 Company Name Reschedge Mailing Address 902 Broadway 6th Floor New York, NY 10010 Company Description Reschedge makes scheduling an interview lineup with 2, 3, 4…15 back-to-back interviews effortless. Imagine having another teammate look at all the possible calendars for your interview and instantly get back to you with who … Continue reading “HireVue Acquires Reschedge for Undisclosed Sum”
Path Lands $25,000,000 Series C Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=826ffa2f-58c2-49a8-bc70-6e59c6079a10 Date 1/11/2014 Company Name Path Mailing Address 301 Howard St. San Francisco, CA 94105 Company Description The company provides a mobile social networking service. Website http://www.path.com Transaction Type Venture Equity Transaction Amount $25,000,000 Transaction Round Series C Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Bakrie Global Group … Continue reading “Path Lands $25,000,000 Series C Financing”
Backupify Obtains $3,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c522b29d-032c-4a8e-9756-e65dd4a00670 Date 1/10/2014 Company Name Backupify Mailing Address 17 Sellers St. Cambridge, MA 02139 Company Description Backupify is not just about backup, it is about controlling your data yourself instead of having it stored in hundreds of services all around the web. Your online data is just as important as the data … Continue reading “Backupify Obtains $3,000,000 New Financing”
Atara Biotherapeutics Lands $13,500,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed490a4c-10be-443b-85d9-da14bd717265 Date 1/10/2014 Company Name Atara Biotherapeutics Mailing Address 2659 Townsgate Road Thousand Oaks, CA 91361 Company Description Our mission is to develop novel treatment options for patients with severe and life-threatening conditions that have been underserved by scientific innovation. We are investigating therapies targeting unique pathways to pause or reverse patients’ … Continue reading “Atara Biotherapeutics Lands $13,500,000 Series B Round”
Suneva Medical Obtains $35,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4df86530-3692-4f2d-b2bf-e7a0ed2542f6 Date 1/10/2014 Company Name Suneva Medical Mailing Address 5383 Hollister Avenue Santa Barbara, CA 93111 Company Description Suneva Medical partners with aesthetic providers to build practices by providing unique aesthetic products that deliver patient satisfaction and build customer loyalty. Website http://www.sunevamedical.com Transaction Type Debt, Venture Equity Transaction Amount $35,000,000 Transaction Round … Continue reading “Suneva Medical Obtains $35,000,000 Series B Financing Round”
Suneva Medical Receives $35,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4df86530-3692-4f2d-b2bf-e7a0ed2542f6 Date 1/10/2014 Company Name Suneva Medical Mailing Address 5383 Hollister Avenue Santa Barbara, CA 93111 Company Description Suneva Medical partners with aesthetic providers to build practices by providing unique aesthetic products that deliver patient satisfaction and build customer loyalty. Website http://www.sunevamedical.com Transaction Type Debt, Venture Equity Transaction Amount $35,000,000 Transaction Round … Continue reading “Suneva Medical Receives $35,000,000 Series B Round”
Vestaron Secures $1,266,919 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2f86dc1a-8090-4df3-9b5b-b6a80624ed67 Date 1/10/2014 Company Name Vestaron Mailing Address 4717 Campus Drive Kalamazoo, MI 49008 Company Description Vestaron Corporation is developing a new generation of insecticides by employing peptides sourced from spiders – insecticides that are ideally suited for the environmentally conscious, twenty-first century. Over 50 unique, spider-venom peptides with novel sites of … Continue reading “Vestaron Secures $1,266,919 New Funding Round”
Whill Secures $1,750,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a1f0e601-8f17-425f-8a24-32f4083aadab Date 1/10/2014 Company Name Whill Mailing Address 120 Independence Dr. Menlo Park, CA 94025 Company Description WHILL Type-A is a next generation personal mobility device to expand your horizon with functionality and style that everyone including wheelchair users can use. Website http://www.whill.jp Transaction Type Venture Equity Transaction Amount $1,750,000 Transaction Round … Continue reading “Whill Secures $1,750,000 Seed Round”
CAN Capital Secures $33,000,000 Series C Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b78ae56e-c68e-4795-b347-6fd45fe713e3 Date 1/10/2014 Company Name CAN Capital Mailing Address 414 W 14th Street 3rd Floor New York, NY 10014 Company Description Since 1998, CAN Capital has been helping small and medium-sized businesses get ahead. Our cutting-edge technology, quick application and approval processes, customer-focused delivery, and great service have kept us at the … Continue reading “CAN Capital Secures $33,000,000 Series C Financing”
Immedia Semiconductor Lands $11,892,857 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0c1de6c2-a6fd-4f5c-9675-9924cda39145 Date 1/9/2014 Company Name Immedia Semiconductor Mailing Address 100 Burtt Rd. Andover, MA 01810 Company Description Immedia Semiconductor, Inc. develops and markets semiconductor based ISP and video compression technologies for consumer electronics applications. Staffed by a world class team of ISP and video compression technology experts, Immedia is the first company … Continue reading “Immedia Semiconductor Lands $11,892,857 New Funding”
FRX Polymers Receives $12,037,414 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c3b2e22e-ca72-4995-b2bb-b74772b8bfbd Date 1/9/2014 Company Name FRX Polymers Mailing Address 200 Turnpike Road Chelmsford, MA 01824 Company Description Welcome to FRX Polymers (FRX), the clear choice for Flame Retardancy. Our polymers are fully transparent, high flowing and due to their high phosphorus content, are inherently non-burning. FRX Polymers is developing Homopolymers and Copolymers … Continue reading “FRX Polymers Receives $12,037,414 New Financing”
ArthroMeda Secures $1,600,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dccdcf50-c282-44bc-9973-d933366bdc4b Date 1/9/2014 Company Name ArthroMeda Mailing Address 75 Sandy Pond Road Ayer, MA 01432 Company Description ArthroMeda Inc., an Ayer, Massachusetts based developer of medical devices. Co-founded by PJ Anand, Chairman, Mehran Aghazadeh, inventor of the technology, ArthroCAD focuses on developing solutions to improve surgical outcomes for patients undergoing joint replacement … Continue reading “ArthroMeda Secures $1,600,000 New Round”
TraceLink Obtains $5,500,829 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fd40e437-ddbe-48cb-ac6e-de9f81bfa0d1 Date 1/9/2014 Company Name TraceLink Mailing Address 200 Quannapowitt Parkway Wakefield, MA 01880 Company Description TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. Website http://www.tracelink.com Transaction Type Venture Equity Transaction Amount $5,500,829 Transaction Round Undisclosed … Continue reading “TraceLink Obtains $5,500,829 New Financing Round”
Aura Biosciences Lands $1,335,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=961c78f1-3cce-48f1-88d1-e471d289720b Date 1/9/2014 Company Name Aura Biosciences Mailing Address 85 Bolton Street Cambridge, MA 02140 Company Description Aura Biosciences is a next generation biotech company – combining the expertise of leading academic institutions through research and licensing agreements, with the flexibility and efficiency of a dedicated team of in-house scientists, deal-makers, and … Continue reading “Aura Biosciences Lands $1,335,000 New Financing”
Avelas Biosciences Garners $6,850,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dba6729d-2f01-43e9-9c57-d8bfcc534694 Date 1/9/2014 Company Name Avelas Biosciences Mailing Address 11099 N. Torrey Pines Road La Jolla, CA 92037 Company Description At Avelas Biosciences, our mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome … Continue reading “Avelas Biosciences Garners $6,850,000 Series B Funding”
Radius Obtains $13,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6ab4ef96-685b-473d-9e73-912d82022f44 Date 1/9/2014 Company Name Radius Mailing Address 140 2nd Street San Francisco, CA 94105 Company Description Radius provides actionable insights for selling to SMBs. Simply put, we are a GeoData platform that powers the local data (places, news, events, reviews, photos, and more) for Partners and Developers who use our API … Continue reading “Radius Obtains $13,000,000 New Round”
Zephyr Health Garners $15,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f0e29a44-e273-4a51-8066-9aa4bdfca25c Date 1/9/2014 Company Name Zephyr Health Mailing Address 589 Howard St. San Francisco, CA 94105 Company Description We value diversity, culture, language, intelligence, honesty and ambition. We work smart. We value the output. We respect different paths that arrive at objectives. Website http://www.zephyrhealthinc.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction … Continue reading “Zephyr Health Garners $15,000,000 Series B Round”
Lumiata Lands $4,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8d9e0c6a-e981-4be5-82d1-b2b4f224b35c Date 1/9/2014 Company Name Lumiata Mailing Address 101 S. Ellsworth San Mateo, CA 94401 Company Description Lumiata is a leading provider predictive health analytics. We are partnering with some of the most respected healthcare organizations in the United States to improve the quality of care for their patients. What we do … Continue reading “Lumiata Lands $4,000,000 Series A Financing Round”
Vobile Secures Series C Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2718f3f5-6870-46f9-872f-dee6e0b2efca Date 1/9/2014 Company Name Vobile Mailing Address 4699 Old Ironsides Drive Santa Clara, CA 95054 Company Description Vobile is a leading provider of video content identification and management services. Its core VideoDNA content identification and management technology enables fully automated identification, tracking and management of any video content, including associated audio, … Continue reading “Vobile Secures Series C Financing”
Compliance Science Garners $8,250,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5a7944e9-524b-4888-9a50-335163ee8146 Date 1/9/2014 Company Name Compliance Science Mailing Address 386 Park Ave South New York, NY 10016 Company Description Compliance Science is a New York City based global leader in providing web-based regulatory compliance technology and services to the Financial Services community. Website http://www.complysci.com Transaction Type Venture Equity Transaction Amount $8,250,000 Transaction … Continue reading “Compliance Science Garners $8,250,000 Series A Round”
Peak Secures $4,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f3efdf9-14cf-4b56-8ddb-ca521b5ebf82 Date 1/9/2014 Company Name Peak Mailing Address Undisclosed Denver, CO 80211 Company Description Established in 2006, Peak began and continues its focus on the Infrastructure-as-a-Service slice of cloud computing delivering public, private, Hybrid, DR, and custom solutions. As a Type II SSAE16/SOC 1 company, we focus on consistently sound operational procedures … Continue reading “Peak Secures $4,000,000 New Round”
Yahoo! Acquires Aviate for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c056a427-fda5-4fe4-b568-d4f440e0eb62 Date 1/9/2014 Company Name Aviate Mailing Address Undisclosed San Francisco, CA 94105 Company Description Aviate is an intelligent homescreen for the Android operating system that organizes the information in your phone and surfaces it at the perfect moment. Website http://www.getaviate.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A … Continue reading “Yahoo! Acquires Aviate for Undisclosed Sum”
Aeglea BioTherapeutics Secures $12,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b381279-ed11-478a-8b38-9f52f4f285c0 Date 1/9/2014 Company Name Aeglea BioTherapeutics Mailing Address 815-A Brazos St. Austin, TX 78701 Company Description Aeglea BioTherapeutics is a Texas based start up developing two drugs invented at UT Austin, novel engineered human enzymes that degrade the amino acids L-methionine (L-Met), or L- arginine (LArg) in the circulation. These drugs … Continue reading “Aeglea BioTherapeutics Secures $12,000,000 New Funding”
NetClarity Lands $260,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=508762bb-99bf-4ead-bfce-b20e4d367435 Date 1/8/2014 Company Name NetClarity Mailing Address 19 Crosby Drive Bedford, MA 01730 Company Description NetClarity develops vulnerability management and intrusion prevention network security products. NetClarity’s new product, called EasyNAC, is designed to identify devices that should be allowed within a network and is expected to be a boon to the … Continue reading “NetClarity Lands $260,000 New Funding”
RailRunner Receives $6,082,611 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=080f2ff0-425c-425d-8d13-e1f4c407f8b5 Date 1/8/2014 Company Name RailRunner Mailing Address 430 Bedford Street Lexington, MA 02420 Company Description To be acknowledged as a leading supplier to the transportation market by developing, manufacturing and marketing safe, progressive, patented, high-quality, and cost effective intermodal and bi-modal products and services to markets worldwide. Website http://www.railrunner.com Transaction Type … Continue reading “RailRunner Receives $6,082,611 New Financing”
Auspex Pharmaceuticals Garners $15,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d64d725c-ec68-43d9-bc5e-0da13b52b5f3 Date 1/8/2014 Company Name Auspex Pharmaceuticals Mailing Address 3366 North Torrey Pines Court La Jolla, CA 92037 Company Description Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs. Website http://www.auspexpharma.com Transaction Type Debt … Continue reading “Auspex Pharmaceuticals Garners $15,000,000 New Financing”
ChowNow Obtains $708,414 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f3482b66-2163-42b5-9c1a-6746e5940fef Date 1/8/2014 Company Name ChowNow Mailing Address 2112 Narcissus Ct. Venice, CA 90291 Company Description ChowNow is a next-generation meal ordering platform that utilizes the latest web, mobile and social networking technologies to expand restaurant’s online ordering capabilities and customer reach. Website http://www.chownow.com Transaction Type Venture Equity Transaction Amount $708,414 Transaction … Continue reading “ChowNow Obtains $708,414 New Financing Round”
Auspex Pharmaceuticals Lands $20,000,000 Series E Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fbba1eae-bcfa-4098-89fa-ea98d4a92784 Date 1/8/2014 Company Name Auspex Pharmaceuticals Mailing Address 3366 North Torrey Pines Court La Jolla, CA 92037 Company Description Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs. Website http://www.auspexpharma.com Transaction Type Venture … Continue reading “Auspex Pharmaceuticals Lands $20,000,000 Series E Financing”
Ablative Solutions Lands $9,575,077 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d8708c5d-eca1-4a90-ac06-c0a3063a8529 Date 1/8/2014 Company Name Ablative Solutions Mailing Address 350 East Michigan Avenue Kalamazoo, MI 49007 Company Description Ablative Solutions’ technology involves endovascular catheters to provide an efficacious, durable, cost-effective and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system. … Continue reading “Ablative Solutions Lands $9,575,077 New Funding Round”
Glooko Obtains $7,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d0c12d6e-86e6-47d9-b099-3814a47b1c04 Date 1/8/2014 Company Name Glooko Mailing Address 170A University Avenue Palo Alto, CA 94301 Company Description Glooko is an innovative Silicon Valley startup with a unique solution for people with diabetes. Our products enable users with smartphones to easily collect and view the information needed to help them successfully control their … Continue reading “Glooko Obtains $7,000,000 Series A Round”
Bell Biosystems Lands $2,058,230 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b34a79b-55c5-4fd6-904d-4ff3f3861d1f Date 1/8/2014 Company Name Bell Biosystems Mailing Address 953 Indiana Street San Francisco, CA 94107 Company Description Bell Biosystems combines expertise in stem cell research, cell biology, oncology, biomedical imaging and molecular biology. Our vision is to create tools that accelerate the “bench-to-bedside” progress of innovations in oncology and cell therapy … Continue reading “Bell Biosystems Lands $2,058,230 Series A Financing Round”